A. Rubboli

发表

Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.

G. Lip, W. Nammas, T. Kiviniemi, 2018, International journal of cardiology.

Impatto della pandemia COVID-19 sui ricoveri per sindrome coronarica acuta: revisione della letteratura ed esperienza monocentrica./ [Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience].

A. Rubboli, L. Fileti, S. Vecchio, 2020 .

[Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience].

A. Rubboli, L. Fileti, S. Vecchio, 2020, Giornale italiano di cardiologia.

Management of acute coronary syndromes in older adults.

S. de Servi, M. Valgimigli, G. De Luca, 2021, European heart journal.

Clinical governance programme in patients with acute coronary syndrome: design and methodology of a quality improvement initiative

S. de Servi, G. Campo, L. Oltrona Visconti, 2020, Open Heart.

Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice

K. Huber, J. Schreieck, M. Gawaz, 2019, Thrombosis and Haemostasis.

Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism

A. Rubboli, S. Vecchio, T. Chechi, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism

A. Jaffe, A. Rubboli, F. Ottani, 2004, Heart.

Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?

D. Atar, A. Rubboli, 2021, American Journal of Cardiovascular Drugs.

Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy.

G. Lip, M. Niemelä, W. Nammas, 2014, Thrombosis research.

Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.

G. Lip, M. Niemelä, S. Vikman, 2012, Circulation journal : official journal of the Japanese Circulation Society.

How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?

G. Lip, A. Schlitt, A. Rubboli, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome

R. Abbate, E. D. Lorenzo, G. Biondi-Zoccai, 2014 .

Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting.

A. Rubboli, G. di Pasquale, 2006, Future cardiology.

The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused.

D. Atar, A. Rubboli, 2021, European journal of internal medicine.

WHY THE FOUR NON-VITAMIN K-ANTAGONIST ORAL ANTICOAGULANTS ARE ACTUALLY FIVE.

A. Rubboli, 2020, European journal of internal medicine.

Horizontal vs. vertical dose reduction of direct oral anticoagulants in patients with non-valvular atrial fibrillation: definition and implications for practice.

A. Rubboli, 2019, European journal of internal medicine.

Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.

W. Ageno, G. Agnelli, A. Rubboli, 2018, International journal of cardiology.

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles.

G. Patti, A. Rubboli, 2017, European journal of internal medicine.

Reduced dose and reduced exposure to non-vitamin K-antagonist oral anticoagulants: Some considerations on this relationship.

F. Verheugt, A. Rubboli, 2016, International journal of cardiology.

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association

P. Kirchhof, G. Lip, G. Boriani, 2014, European heart journal.

Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?

G. Lip, J. Oldgren, A. Rubboli, 2013, Internal and Emergency Medicine.

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.

G. Lip, K. Huber, S. Agewall, 2015, International journal of cardiology.

Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.

F. Verheugt, A. Rubboli, C. Becattini, 2011, World journal of cardiology.

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study

A. di Lenarda, L. De Luca, A. Rubboli, 2020, BMJ Open.

Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis

G. Boriani, D. Capodanno, A. Rubboli, 2020, Expert review of cardiovascular therapy.

From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

A. Rubboli, B. Rocca, E. Barbaresi, 2019, Cardiovascular Drugs and Therapy.

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European

G. Lip, L. Fauchier, M. Valgimigli, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.

A. M. Leone, M. Dallago, P. Calabrò, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry

J. Hartikainen, G. Lip, W. Nammas, 2017, Clinical cardiology.

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

G. Lip, J. Airaksinen, T. Kiviniemi, 2017, American heart journal.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

P. Kirchhof, G. Lip, T. Kiviniemi, 2015, International journal of cardiology.

Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.

J. DiNicolantonio, S. Bangalore, F. Gaita, 2015, The American journal of cardiology.

Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.

G. Lip, M. Niemelä, S. Vikman, 2014, The American journal of cardiology.

Management of antithrombotic therapy in atrial fibrillation patientspresentingwith acutecoronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart

L. Fauchier, T. Potpara, J. Tamargo, 2014 .

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting

Deepak L. Bhatt, G. Lip, D. Faxon, 2014, Thrombosis and Haemostasis.

The WOEST study: Critical considerations and applicability

A. Rubboli, R. Caterina, 2014 .

Antiplatelet therapy and anticoagulants

G. Lip, A. Schlitt, A. Rubboli, 2013, The Lancet.

THE WOEST STUDY: IS NOW THE TIME TO UPDATE THE RECOMMENDATIONS REGARDING THE ANTITHROMBOTIC THERAPY IN PATIENTS WITH INDICATION FOR ORAL ANTICOAGULATION UNDERGOING CORONARY STENT IMPLANTATION?

A. Rubboli, 2013 .

Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting

B. Cosmi, A. Rubboli, M. Milandri, 2005, Cardiology.

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry

G. Lip, T. Kiviniemi, A. Schlitt, 2017, Clinical Research in Cardiology.

Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies

G. Campo, A. Rubboli, M. Tebaldi, 2021, Journal of clinical medicine.

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio

B. Gorenek, G. Boriani, L. Fauchier, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease

F. Zaccardi, A. Rubboli, B. Rocca, 2019, European journal of preventive cardiology.

New‐generation drug‐eluting stents reduce stent thrombosis and myocardial infarction: A propensity‐score‐adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia‐Romagna)

D. Ardissino, R. Mehran, A. Rubboli, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms

M. Moia, S. Testa, A. Rubboli, 2013, Internal and Emergency Medicine.

Percutaneous artErial closure devices and ultrasound‐guided Trans‐femoRal puncture ObservatioNal InvestigatiOn: Insights from the PETRONIO registry

A. Somaschini, A. Rubboli, G. di Pasquale, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction

A. Rubboli, 2008, Current cardiology reviews.

Low-Molecular-Weight Heparins in Conjunction with Thrombolysis for ST-Elevation Acute Myocardial Infarction

A. Rubboli, M. Galvani, F. Ottani, 2006, Cardiology.

ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes

P. Trambaiolo, F. Oliva, R. Rossini, 2022, European heart journal supplements : journal of the European Society of Cardiology.

CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.

G. Lip, M. Niemelä, P. Karjalainen, 2014, Thrombosis research.

Clinical management of rivaroxaban-treated patients

W. Ageno, G. Palareti, A. Rubboli, 2013, Expert opinion on pharmacotherapy.

[How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?].

A. Rubboli, G. di Pasquale, 2008, Giornale italiano di cardiologia.

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

G. Lip, J. Halperin, A. Gershlick, 2008, Annals of medicine.

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial

G. Lip, J. Airaksinen, T. Kiviniemi, 2015, PloS one.

ALGORITHM FOR THE MANAGEMENT OF ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN UPDATED PROPOSAL BASED ON EFFICACY CONSIDERATIONS.

G. Lip, A. Rubboli, 2020, European heart journal. Cardiovascular pharmacotherapy.

CHOICES IN ANTITHROMBOTIC MANAGEMENT FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. QUESTIONS (AND ANSWERS) IN CHRONOLOGICAL SEQUENCE.

G. Lip, M. Valgimigli, D. Capodanno, 2020, European heart journal. Cardiovascular pharmacotherapy.

Combinations of Antithrombotic Therapies Prescribed after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes and Atrial Fibrillation: Data from the Nationwide MATADOR-PCI Registry.

A. di Lenarda, L. De Luca, A. Rubboli, 2020, European heart journal. Cardiovascular pharmacotherapy.

Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?

J. Collet, A. Rubboli, 2020, European heart journal. Cardiovascular pharmacotherapy.

And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?

A. Rubboli, 2019, European journal of internal medicine.

After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention?

A. Rubboli, M. Lisi, 2019, Cardiovascular Drugs and Therapy.

What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110mg twice daily and clopidogrel in the RE-DUAL PCI trial?

A. Rubboli, 2017, European journal of internal medicine.

Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug?

A. Rubboli, 2017, European journal of internal medicine.

Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry

P. Kirchhof, G. Lip, J. Airaksinen, 2014, BMJ Open.

Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician.

F. Verheugt, A. Rubboli, 2008, International journal of cardiology.

Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention

A. Rubboli, G. di Pasquale, P. Sangiorgio, 2007, Coronary artery disease.

A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry

A. Maggioni, A. Rubboli, M. Galvani, 2009, Journal of cardiovascular medicine.

Pre- and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes

I. Porto, J. Borovac, A. Rubboli, 2021, Journal of cardiovascular medicine.

Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation.

M. Henein, F. D’Ascenzi, M. Cameli, 2021, European heart journal. Cardiovascular Imaging.

Effective Treatment of Intermediate-Risk Pulmonary Embolism by Manual Thrombus Aspiration. A Report of Two Cases.

A. Rubboli, D. Buccheri, B. Cortese, 2015, Heart, Lung and Circulation.

Association of cholesterol levels and occurrence of angiographically detectable endothelial disruption during coronary angioplasty

A. Rubboli, D. Euler, G. Casella, 2003, Clinical cardiology.

Utilizing enoxaparin in the management of STEMI

A. Rubboli, G. di Pasquale, A. Capecchi, 2007, Vascular health and risk management.

Impedance mapping with constant contact force on 3D electroanatomic map to characterize tissues at pulmonary veno-atrial junction

S. Severi, C. Corsi, A. Rubboli, 2020, Journal of Interventional Cardiac Electrophysiology.

Systematic coronary stenting after failed thrombolysis in high‐risk patients with acute myocardial infarction: procedural results and long‐term follow‐up

A. Rubboli, F. Ottani, L. Favero, 2003, Coronary artery disease.

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?

A. di Lenarda, M. Uguccioni, L. De Luca, 2021, Open Heart.

Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.

A. di Lenarda, L. De Luca, A. Rubboli, 2021, European journal of internal medicine.

Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting.

A. Rubboli, 2010, World journal of cardiology.

The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update

A. Rubboli, 2012, Internal and Emergency Medicine.

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

A. Rubboli, 2013 .

In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study

G. Boriani, D. Ardissino, M. Piepoli, 2021, The Lancet Regional Health - Europe.

Could the PARIS Risk Scores Be Useful for the Choice of Triple versus Dual Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention?

L. De Luca, A. Rubboli, M. Gulizia, 2022, Cardiology.

Pro: ‘Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions’

J. Halperin, A. Rubboli, 2008, Thrombosis and Haemostasis.

Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?

G. Lip, J. Airaksinen, A. Schlitt, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.

G. Lip, M. Niemelä, T. Kiviniemi, 2013, The American journal of cardiology.

The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.

A. Rubboli, G. di Pasquale, 2006, European heart journal.

Exercise-induced ventricular arrhythmias in patients with healed myocardial infarction.

A. Rubboli, G. Casella, P. Pavesi, 1993, International journal of cardiology.

Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.

T. Chao, L. Fauchier, T. Potpara, 2022, Thrombosis and haemostasis.

Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers

A. Santarelli, A. Rubboli, L. Fileti, 2020, Journal of cardiovascular medicine.

Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus

G. Parati, M. Senni, M. Uguccioni, 2022, Cardiovascular Diabetology.

RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.

A. Rubboli, S. Veronese, N. Morici, 2022, Thrombosis and haemostasis.

Antonio Maria Valsalva

J. Hurst, A. Rubboli, W. Fye, 2003, Clinical cardiology.

Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications

M. Henein, F. D’Ascenzi, M. Cameli, 2022, Heart Failure Reviews.

Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?

A. Rubboli, 2018, International journal of cardiology.

Letter by Marín et al regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

L. Fauchier, A. Rubboli, F. Marín, 2013, Circulation.

The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies

S. Volpato, R. Ferrari, G. Campo, 2021, Journal of cardiovascular medicine.

Pericarditis following acute coronary syndrome: epidemiology and treatment

A. Rubboli, A. Brucato, N. Morici, 2021, Internal and Emergency Medicine.

Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart

J. Grapsa, J. Mehilli, E. Grove, 2021, European heart journal.

antithrom-Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

A. Rubboli, 2014 .

Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal.

A. Rubboli, G. di Pasquale, 2015, International journal of cardiology.

Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center.

A. Rubboli, G. di Pasquale, P. Sangiorgio, 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry

G. Campo, A. Rubboli, A. Sciahbasi, 2022, Indian heart journal.

Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registry

P. Calabrò, A. Rubboli, F. Saia, 2015, Journal of cardiovascular medicine.

New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose.

G. Lip, K. Huber, S. Agewall, 2017, European journal of internal medicine.

Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent

G. Musumeci, P. Calabrò, G. Renda, 2022, Journal of cardiovascular medicine.

Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.

A. Rubboli, M. Galvani, F. Ottani, 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

470 Percutaneous arterial closure devices and ultrasound-guided trans-femoral puncture observational investigation: insights from the PETRONIO registry

A. Somaschini, A. Rubboli, G. Casella, 2021, European Heart Journal Supplements.

Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.

M. Valgimigli, G. Sangiorgi, A. Maggioni, 2014, The Journal of invasive cardiology.

Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence

A. Rubboli, G. Pasquale, 2007, Internal and emergency medicine.

Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention

G. Lip, M. Niemelä, T. Kiviniemi, 2013 .

[Antithrombotic treatments in patients with SARS-CoV-2 infection: from current evidence to reasonable recommendations - A position paper from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology].

P. Calabrò, G. Patti, A. Rubboli, 2020, Giornale italiano di cardiologia.

Antiplatelet therapy after coronary bypass grafting: which regimen and for whom?

A. Rubboli, S. Vecchio, 2020, European heart journal. Cardiovascular pharmacotherapy.

Mechanisms of late stent malapposition after primary stenting in ST-elevation myocardial infarction: a subanalysis of the selection trial.

A. Rubboli, G. Baldereschi, S. Vecchio, 2009, Journal of interventional cardiology.

Adherence to and persistence with non-vitamin K-antagonist oral anticoagulants: does the number of pills per day matter?

A. Rubboli, 2015, Current medical research and opinion.

Antithrombotic therapy after coronary stenting in patients with indication for oral anticoagulation: Reply

F. Verheugt, A. Rubboli, 2009 .

Left atrial myocardial intrinsic function remodeling response to repair of primary mitral regurgitation

M. Henein, M. Cameli, M. Focardi, 2022, Echocardiography.

University of Birmingham Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention

J. Airaksinen, W. Nammas, T. Kiviniemi, 2014 .

Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting.

A. Rubboli, J. Valencia, L. Zanolla, 2009, Journal of interventional cardiology.

What is the Role for Glycoprotein IIb/IIIa Inhibitor Use in the Catheterization Laboratory in the Current Era?

G. Patti, A. Rubboli, 2018, Current vascular pharmacology.

Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart.

P. Sobotka, A. Rubboli, D. Euler, 1994, The American journal of physiology.

Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice.

A. Rubboli, G. di Pasquale, P. Sangiorgio, 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

P1177Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

G. Lip, T. Kiviniemi, A. Schlitt, 2018 .

Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology.

C. Cuccia, P. Calabrò, G. Patti, 2022, Vascular pharmacology.

Left Atrial Remodeling in Response to Aortic Valve Replacement: Pathophysiology and Myocardial Strain Analysis

M. Henein, M. Cameli, M. Focardi, 2022, Life.

Contemporary antithrombotic treatment after coronary stenting in patients with indication for long-term anticoagulation.

A. Rubboli, G. di Pasquale, P. Sangiorgio, 2006, Minerva cardioangiologica.

Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry

G. Musumeci, L. Barbieri, G. Campo, 2021, International Journal of Cardiology.

[ST segment depression during recovery after treadmill exercise test in stable patients with previous myocardial infarction].

A. Rubboli, M. Medda, G. Casella, 1996, Giornale italiano di cardiologia.

Acute total occlusion of the right coronary artery by a pellet.

A. Rubboli, L. La Vecchia, A. Fontanelli, 2001, Circulation.

Bleeding risk assessment and management in atrial fibrillation patients

P. Kirchhof, G. Lip, L. Fauchier, 2011, Thrombosis and Haemostasis.

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.

John Camm, Paulus Kirchhof, Gregory Y H Lip, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

P. Kirchhof, M. Niemelä, S. Vikman, 2014, Clinical cardiology.

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

E. Grove, C. Patrono, C. Baigent, 2018, European heart journal.

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

G. Lip, K. Huber, T. Cuisset, 2011, Thrombosis and Haemostasis.

Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic

Spiros C. Denaxas, A. Banerjee, H. Hemingway, 2020, medRxiv.

Left atrial appendage thrombosis in a patient with Friedreich Ataxia–related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation

A. Rubboli, S. Boarin, C. Tomasi, 2021, SAGE open medical case reports.

How Safe Is Anticoagulant Therapy in Older Patients and What Should Be the INR Target

A. Rubboli, V. Carinci, G. Casella, 2006 .

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease

M. L. La Rovere, G. Gensini, A. Maggioni, 2018, European heart journal supplements : journal of the European Society of Cardiology.

Left ventricular pseudoaneurysm protruding outside the chest wall.

A. Rubboli, G. di Pasquale, M. Colletta, 2006, Journal of cardiovascular medicine.

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

G. Procaccianti, A. Rubboli, A. Zaniboni, 2015 .

Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation.

S. de Servi, L. De Luca, A. Rubboli, 2017, International journal of cardiology.

Ticlopidine versus oral anticoagulation for coronary stenting.

B. Cosmi, A. Rubboli, B Cosmi, 2001, The Cochrane database of systematic reviews.

In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.

L. Moroni, M. Valgimigli, A. Maggioni, 2013, The Journal of invasive cardiology.

Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation.

A. Rubboli, G. di Pasquale, M. Colletta, 2005, American heart journal.

The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation

P. Kirchhof, M. Niemelä, S. Vikman, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention.

P. Kirchhof, G. Lip, P. Karjalainen, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology

P. Calabrò, G. Patti, A. Rubboli, 2020, American Journal of Cardiovascular Drugs.

Antithrombotic management in the acute coronary syndrome setting

A. Rubboli, 2012 .

Appropriateness of the use of coronary angiography in a population of patients with ischemic heart disease.

A. Rubboli, G. Casella, L. La Vecchia, 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study

S. Volpato, G. Campo, A. Rubboli, 2019, Cardiovascular Drugs and Therapy.

Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation

W. Ageno, A. Rubboli, J. Beyer-Westendorf, 2017, Expert opinion on pharmacotherapy.

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

P. Colonna, R. de Caterina, G. Boriani, 2017, Advances in Therapy.

Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial

J. Myers, S. Volpato, G. Sella, 2020, Heart.

Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement

M. Bertini, C. Rapezzi, R. Ferrari, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis.

M. Bernardi, F. Trevisani, A. Rubboli, 1991, Journal of hepatology.

How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group

C. Cuccia, G. Patti, A. Rubboli, 2021, Journal of cardiovascular medicine.

Incidence and mortality of infective endocarditis in the last decade: a single center study

D. Mele, M. Henein, M. Cameli, 2022, Journal of cardiovascular medicine.

Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta‐analysis of observational studies

J. Airaksinen, S. Bangalore, A. Rubboli, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).

A. Santarelli, A. Rubboli, G. Percoco, 2008, The American journal of cardiology.

The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.

G. Lip, S. Windecker, K. Huber, 2012, Journal of interventional cardiology.

Acute, periprocedural and longterm antithrombotic therapy in older adults.

C. Patrono, B. Gigante, J. Morais, 2022, European heart journal.

2021 ESC/EACTS Guidelines for the management of valvular heart disease.

B. Prendergast, N. Freemantle, M. Jahangiri, 2021, European heart journal.

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis

A. Rubboli, R. Grilli, R. De Palma, 2012, Thrombosis Journal.

Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study.

A. Rubboli, G. Cavallotti, S. Savonitto, 1990, European heart journal.

De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis

M. Valgimigli, J. T. ten Berg, D. Sibbing, 2023, Nature Reviews Cardiology.

The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions

A. Rubboli, 2011, Journal of geriatric cardiology : JGC.

Long-Term Risk of Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome: Prognostic Role of Complete Blood Cell Count

C. la Vecchia, C. Giannattasio, M. Valgimigli, 2020, Angiology.

2021 ESC/EACTS Guidelines for the management of valvular heart disease.

B. Prendergast, N. Freemantle, M. Jahangiri, 2021, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism

A. Rubboli, S. Vecchio, T. Chechi, 2009 .

Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.

G. Lip, R. Mehran, J. Kovacic, 2011, Chest.

Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry).

G. Campo, A. Rubboli, R. De Palma, 2012, The American journal of cardiology.